…ey injury (AKI) (relative risk (RR) 1.75, 95% CI 1.40 to 2.19), chronic kidney disease (CKD) (RR 1.35, 95% CI 1.15 to 1.56), gastric cancers (GC) (RR …
gastric cancers
This disease is selected. Its supporting articles are shown below.
Articles mentioning gastric cancers
6 articles · page 1 of 1…Background ERBB2/HER2 is overexpressed or mutated in ~15% of gastric cancers due to amplification or mutation of the ERBB2 locus. While the …
…e of surface proteins amenable to CAR-T cell-based therapies in solid tumors.…
…se of programmed death-ligand 1 (PD-L1) immunohistochemistry in gastrointestinal cancers, most immune checkpoint inhibitor trials fail to stratify meani…
…ptor 2 (HER2; ERBB2) is overexpressed or amplified in 15–20% of gastric cancers (HER2+ GC). Within individual HER2+ GCs, HER2/ERBB2 expression …
…s CGRP and RAMP1 expression in primary colorectal cancer (CRC), CRC liver metastases and gastric cancers (GC). RAMP1 expression was…